US · RDGT
Ridgetech Inc.
- Sector
- Healthcare · Medical - Distribution
- Headquarters
- Hangzhou 310008
- Website
- jiuzhou360.com
Price · as of 2025-03-31
$1.39
Market cap 9.25M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $377.95 | +27,090.65% |
| Intrinsic Value(DCF) | $0.38 | -72.66% |
| Graham-Dodd Method(GD) | $14.28 | +927.19% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $432.00 | $171,722.68 | $0.00 | $1,525.06 | $5,155.42 |
| 2012 | $237.60 | $109,195.52 | $3.07 | $1,620.05 | $5,964.53 |
| 2013 | $151.20 | $22,727.18 | $0.00 | $0.00 | $0.00 |
| 2014 | $388.80 | $69,809.70 | $0.00 | $0.00 | $7,339.06 |
| 2015 | $818.40 | $859.48 | $131.41 | $344.16 | $324.65 |
| 2016 | $381.60 | $960.31 | $137.11 | $321.34 | $154.97 |
| 2017 | $429.60 | $22,450.73 | $138.54 | $0.00 | $0.00 |
| 2018 | $360.00 | $29,437.10 | $0.28 | $0.00 | $0.00 |
| 2019 | $261.60 | $686.05 | $2,178.98 | $112.25 | $0.00 |
| 2020 | $398.40 | $1,608.45 | $2,755.66 | $0.00 | $0.00 |
| 2021 | $237.60 | $7,266.45 | $2,036.90 | $0.00 | $0.00 |
| 2022 | $53.20 | $20,530.66 | $11,525.44 | $46.70 | $0.00 |
| 2023 | $14.60 | $1,539.99 | $0.00 | $0.00 | $35.69 |
| 2024 | $2.90 | $73.73 | $1.01 | $0.00 | $0.00 |
| 2025 | $0.96 | $377.95 | $0.00 | $14.28 | $0.00 |
AI valuation
Our deep-learning model estimates Ridgetech Inc.'s (RDGT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $377.95
- Current price
- $1.39
- AI upside
- +27,090.65%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.38
-72.66% upside
Graham-Dodd
$14.28
+927.19% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| RDGT | Ridgetech Inc. | $1.39 | 9.25M | +27,091% | -73% | +927% | — | 0.52 | 0.18 | 0.04 | 0.59 | — | 0.21 | 3.20% | -0.86% | 8.50% | 45.06% | -3.14% | 12.79% | 0.35 | — | 1.74 | 1.25 | -0.48 | -16280.00% | -2237.00% | -11551.00% | 11.89% | 0.04 | 1.92% | 0.00% | 0.00% | 478.51% | -2.83 | 4.63 | 0.02 | 1.00 |
| ADVB | Advanced Biomed Inc. Comm… | $4.06 | 4.4M | — | — | — | — | -1690.19 | 0.05 | — | — | -7324.16 | 0.05 | 0.00% | — | — | -0.01% | 0.00% | 0.00% | 0.00 | — | 2.09 | 1.01 | — | 2308.00% | — | -9171.00% | -0.11% | 0.00 | -0.06% | 0.00% | 0.00% | 1690.13% | — | 14968.87 | — | -3.52 |
| APM | Aptorum Group Limited | $0.78 | 4.95M | +30,801% | — | — | — | -1.20 | 0.24 | — | -2.03 | -4.65 | 0.24 | 0.00% | — | — | -18.56% | -15.20% | -23.21% | 0.16 | -25.84 | 0.22 | 0.20 | -0.66 | 2581.00% | -10000.00% | -8459.00% | -23.24% | -0.27 | -4.77% | 0.00% | 0.00% | 0.00% | -2.00 | -6.39 | — | -6.61 |
| BGLC | BioNexus Gene Lab Corp. | $2.72 | 4.89M | +1,907% | +316% | -93% | — | -4.11 | 0.79 | 0.69 | -1.70 | — | 0.79 | 13.56% | -16.55% | -16.81% | -17.78% | -39.19% | -14.64% | 0.03 | -74.42 | 3.81 | 3.05 | 2.93 | -4118.00% | -266.00% | 2885.00% | -37.43% | -1.15 | -61.29% | 0.00% | 0.00% | 0.00% | -1.53 | -0.98 | 0.25 | 2.45 |
| CLRB | Cellectar Biosciences, In… | $3.25 | 10.36M | — | — | — | — | -0.26 | 0.82 | — | 0.22 | — | 0.82 | 0.00% | — | — | -17221.69% | 330.97% | -237.45% | 0.03 | — | 2.58 | 2.48 | 0.44 | -6010.00% | — | 4346.00% | -406.92% | -5.07 | 304.82% | 0.00% | 0.00% | 117.61% | 0.21 | 0.23 | — | -18.97 |
| MRKR | Marker Therapeutics, Inc. | $1.48 | 15.98M | +3,230% | -2% | — | — | -1.26 | 0.73 | 2.04 | 0.51 | — | 0.73 | -104.33% | -168.69% | -162.82% | -65.81% | 1313.50% | -54.82% | 0.00 | — | 6.36 | 6.22 | 1.73 | -3834.00% | 9906.00% | -3364.00% | -81.00% | -3.15 | 1288.92% | 0.00% | 0.00% | 30.30% | 0.51 | 0.52 | -0.87 | -26.44 |
| SCNX | Scienture Holdings, Inc. | $0.43 | 6.62M | +16,080% | +1,925% | — | — | -0.29 | 0.07 | 39.03 | -0.49 | — | -0.29 | 4.39% | -10758.70% | 6634.66% | -45.83% | -31.88% | -31.08% | 0.04 | -11.01 | 0.80 | 0.73 | -0.19 | -13311.00% | -8998.00% | 54162.00% | -267.71% | -1.80 | -31.87% | 278.62% | -81.40% | 344.99% | -0.58 | -0.60 | 62.63 | -0.88 |
| TNON | Tenon Medical, Inc. | $0.87 | 7.5M | +21,018% | +210,838% | — | — | -0.12 | 0.26 | 0.48 | 0.35 | — | 0.26 | 52.21% | -420.08% | -417.24% | -405.19% | -38777.46% | -168.93% | 0.07 | -404.88 | 4.39 | 3.96 | 0.47 | -8360.00% | 1192.00% | -1977.00% | -637.69% | -5.29 | -28349.30% | 0.00% | 0.00% | 350.78% | 0.33 | 0.45 | -1.38 | -13.04 |
| TRIB | Trinity Biotech plc | $0.72 | 7.47M | +6,885% | -61% | — | — | -0.39 | -0.35 | 0.20 | -6.39 | — | -0.14 | 34.83% | -34.38% | -51.64% | 107.52% | -42.24% | -39.07% | -2.86 | -2.21 | 1.28 | 0.62 | -5.65 | -4469.00% | 831.00% | 1533.00% | -115.03% | -0.13 | -28.45% | 0.00% | 0.00% | 0.00% | -5.10 | -7.58 | 1.75 | -0.99 |
| XAIR | Beyond Air, Inc. | $0.96 | 4.87M | +6,086% | +58% | — | — | -0.27 | 0.95 | 3.47 | -0.42 | — | 1.04 | -44.89% | -1202.08% | -1258.43% | -250.98% | -332.73% | -111.42% | 0.86 | -14.75 | 3.20 | 1.56 | -0.17 | -6210.00% | 21967.00% | -2859.00% | -342.82% | -7.64 | -329.47% | 0.00% | 0.00% | 0.00% | -0.40 | -0.40 | 4.76 | -17.17 |
About Ridgetech Inc.
Ridgetech Inc operates as a holding company. The Company, through its subsidiaries, wholesales, distributes, and retails pharmaceutical and other healthcare products.
- CEO
- Ming Zhao
- Employees
- 939
- Beta
- -0.31
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.38 ÷ $1.39) − 1 = -72.66% (DCF, example).